1. Aksoylar S, Aydinok Y, Serdaroglu E, Coker M, Ozdemir F, Ozkinay F:
HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome presenting
with hypocalcemia-induced generalized psoriasis.
J Pediatr Endocrinol Metab 2004, 17: 1031-1034.
2. Aydinok Y, Erermis S, Bukusoglu N, Yilmaz D, Solak U: Psychosocial
implications of Thalassemia Major.
Pediatr Int 2005, 47: 84-89.
3. Bilenoglu O, Basak AN, Russell JE: A 3'UTR mutation affects beta-globin
expression without altering the stability of its fully processed mRNA.
Br J Haematol 2002, 119: 1106-1114.
4. Borgatti M, Finotti A, Romanelli A, Saviano M, Bianchi N, Lampronti I et
al.: Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors
as a tool to modify gene expression.
Curr Drug Targets 2004, 5: 735-744.
5. Canatan D, Karadoan C, Balta N, Oguz N, Cosan R, Cengiz O et al.:
Different desferrioxamine usage in the patients with thalassemia major: a cost-effect
analysis.
Turk J Haematol 2004, 21: 173-176.
6. Cariolou MA, Kokkofitou A, Manoli P, Christou S, Karagrigoriou A, Middleton
L: Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot
population of Cyprus.
Genet Epidemiol 1995, 12: 489-497.
7. Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E:
Thalassemia.
Hematology Am Soc Hematol Educ Program 2004, 14-34.
8. Davies JK, Telfer P, Cavenagh JD, Foot N, Neat M: Autoimmune cytopenias
in the 22q11.2 deletion syndrome.
Clin Lab Haematol 2003, 25: 195-197.
9. Del Vecchio L, Locatelli F: [Innovations in dialytic therapy and
daily clinical problems: anemia]. G Ital Nefrol 2004, 21 Suppl 30: S46-S48.
10. Di Filippo S, Manzoni C, Locatelli F: [The use of dialysate conductivity
in the sodium and urea kinetic models]. G Ital Nefrol 2004, 21 Suppl
30: S54-S57.
11. Di Giacomo F, Luca F, Anagnou N, Ciavarella G, Corbo RM, Cresta
M et al.: Clinal patterns of human Y chromosomal diversity in continental Italy
and Greece are dominated by drift and founder effects. Mol Phylogenet
Evol 2003, 28: 387-395.
12. Di Giacomo F, Luca F, Popa LO, Akar N, Anagnou N,
Banyko J et al.: Y chromosomal haplogroup J as a signature of the post-neolithic
colonization of Europe. Hum Genet 2004, 115: 357-371.
13. El Beshlawy
A, Ragab L, Fattah AA, Ibrahim IY, Hamdy M, Makhlouf A et al.: Improvement of
cardiac function in thalassemia major treated with L-carnitine. Acta
Haematol 2004, 111: 143-148.
14. El Beshlawy A, Hussein HA, Abou-Elew HH, Abdel
Kader MS: Study of protein C, protein S, and antithrombin III in hypoxic newborns.
Pediatr Crit Care Med 2004, 5: 163-166.
15. Fattoum S, Messaoud T, Bibi A:
Molecular basis of beta-thalassemia in the population of Tunisia. Hemoglobin
2004, 28: 177-187.
16. Fenech AG, Billington CK, Swan C, Richards S, Hunter
T, Ebejer MJ et al.: Novel polymorphisms influencing transcription of the human
CHRM2 gene in airway smooth muscle. Am J Respir Cell Mol Biol 2004,
30: 678-686.
17. Feriotto G, Finotti A, Volpe P, Treves S, Ferrari S, Angelelli
C et al.: Myocyte enhancer factor 2 activates promoter sequences of the human
AbetaH-J-J locus, encoding aspartyl-beta-hydroxylase, junctin, and junctate.
Mol Cell Biol 2005, 25: 3261-3275.
18. Galanello R, Perseu L, Perra C, Maccioni
L, Barella S, Longinotti M et al.: Somatic deletion of the normal beta-globin
gene leading to thalassaemia intermedia in heterozygous beta-thalassaemic patients.
Br J Haematol 2004, 127: 604-606.
19. Giordano PC, Bouva MJ, Harteveld CL:
A confidential inquiry estimating the number of patients affected with sickle cell
disease and thalassemia major confirms the need for a prevention strategy in the
Netherlands. Hemoglobin 2004, 28: 287-296.
20. Gohari LH, Petrou M,
Felekis X, Christopoulos G, Kleanthous M: Identification of alpha-thalassemia
mutations in Iranian individuals with abnormal hematological indices and normal
Hb A2. Hemoglobin 2003, 27: 129-132.
21. Goldberg Z, Levav Y, Krichevsky
S, Fibach E, Haupt Y: Treatment of chronic myeloid leukemia cells with imatinib
(STI571) impairs p53 accumulation in response to DNA damage. Cell Cycle
2004, 3: 1188-1195.
22. Grinberg L, Fibach E, Amer J, Atlas D: N-acetylcysteine
amide, a novel cell-permeating thiol, restores cellular glutathione and protects
human red blood cells from oxidative stress. Free Radic Biol Med 2005,
38: 136-145.
23. Karvounis HI, Zaglavara TA, Parharidis GE, Nouskas IG, Hassapopoulou EP, Gemitzis
KD et al.: An angiotensin-converting enzyme inhibitor improves left ventricular
systolic and diastolic function in transfusion-dependent patients with beta-thalassemia
major. Am Heart J 2001, 141: 281.
24. Kitsiou-Tzeli S, Kolialexi A,
Fryssira H, Galla-Voumvouraki A, Salavoura K, Kanariou M et al.: Detection of
22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
In Vivo 2004, 18: 603-608.
25. Kyriacou K, Kyrri A, Kalogirou E, Vasiliades P, Angastiniotis M, Ioannou PA
et al.: Hb Bart's levels in cord blood and alpha-thalassemia mutations in Cyprus.
Hemoglobin 2000, 24: 171-180.
26. Kyrri A, Felekis X, Kalogerou E, Christopoulos G, Makariou C, Loizidou D et
al.: Hb Limassol [beta8(A5)Lys-->Asn]: a new hemoglobin variant.
Hemoglobin 2001, 25: 421-424.
27. Makhoul NJ, Wells RS, Kaspar H, Shbaklo H, Taher A, Chakar N et al.:
Genetic heterogeneity of Beta thalassemia in Lebanon reflects historic and recent
population migration. Ann Hum Genet 2005, 69: 55-66.
28. Medici J, Wettinger S, Scerri C, Grochowska A, Felice AE: Comparative
frequency of coagulation factor II and coagulation factor V alleles among new-born
and senior citizens. Malta Med J 2006, 17: 20-27.
29. Modell B, Khan M, Darlison M: Survival in beta-thalassaemia major in
the UK: data from the UK Thalassaemia Register. Lancet 2000, 355: 2051-2052.
30. Modell B, Khan M, Darlison M, King A, Layton M, Old J et al.: A national
register for surveillance of inherited disorders: beta thalassaemia in the United
Kingdom. Bull World Health Organ 2001, 79: 1006-1013.
31. New HV, Cale CM, Tischkowitz M, Jones A, Telfer P, Veys P et al.: Nijmegen
breakage syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer 2005,
44: 494-499.
32. Old J: Haematological Applications: Hemoglobinopathies. In
Methods in Molecular Medicine: Molecular Diagnosis of Genetic Diseases. Edited by
Mountford R, Elles R. Totowa NJ: Humana Press Inc.; 2004:203-219.
33. Oren H, Devecioglu O, Ertem M, Vergin C, Kavakli K, Meral A et al.:
Analysis of pediatric thrombotic patients in Turkey. Pediatr Hematol Oncol
2004, 21: 573-583.
34. Otrock ZK, Mahfouz RA, Taher AT: Should we screen Eastern Mediterranean
sickle beta-thalassemia patients for inherited thrombophilia? J Thromb
Haemost 2005, 3: 599-600.
35. Parera MC, van Dooren M, van Kempen M, de Krijger R, Grosveld F, Tibboel D et
al.: Distal angiogenesis: a new concept for lung vascular morphogenesis.
Am J Physiol Lung Cell Mol Physiol 2005, 288: L141-L149.
36. Patrinos GP, de Krom M, de Boer E, Langeveld A, Imam AM, Strouboulis J et al.:
Multiple interactions between regulatory regions are required to stabilize an active
chromatin hub. Genes Dev 2004, 18: 1495-1509.
37. Patrinos GP, Wajcman H: Recording human globin gene variation.
Hemoglobin 2004, 28: v-vii.
38. Patrinos GP, Giardine B, Riemer C, Miller W, Chui DH, Anagnou NP et al.: Improvements
in the HbVar database of human hemoglobin variants and thalassemia mutations for
population and sequence variation studies. Nucleic Acids Res 2004, 32: D537-D541.
39. Ropero P, Murga MJ, Gonzalez FA, Polo M, Benavente C, Salvador M et al.: The
first case of Hb E-Saskatoon associated with Hb Lepore-Baltimore found in Spain.
Hemoglobin 2005, 29: 215-219.
40. Ropero P, Villegas A, Martinez M, Ataulfo Gonzalez FF, Benavente C, Mateo M:
A deletion of 11 bp (CD 131-134) in exon 3 of the beta-globin gene produces
the phenotype of inclusion body beta-thalassemia. Ann Hematol 2005,
84: 584-587.
41. Santoro N, Giordano P, Del Vecchio GC, Guido G, Rizzari C, Varotto S et al.:
Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective
study. J Pediatr Hematol Oncol 2005, 27: 153-157.
42. Siala H, Fattoum S, Messaoud T, Ouali F, Gerard N, Krishnamoorthy R:
A novel alpha-thalassemia nonsense mutation in codon 23 of the alpha2-globin gene
(GAG-->TAG) in a Tunisian family. Hemoglobin 2004, 28: 249-254.
43. Skordis N, Christou S, Koliou M, Pavlides N, Angastiniotis M: Fertility
in female patients with thalassemia. J Pediatr Endocrinol Metab 1998, 11
Suppl 3: 935-943.
44. Stankov K, Pastore A, Toschi L, McKay J, Lesueur F, Kraimps JL et al.:
Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors.
Int J Cancer 2004, 111: 463-467.
45. Tadmouri GO, Garguier N, Demont J, Perrin P, Basak AN: History and origin
of beta-thalassemia in Turkey: sequence haplotype diversity of beta-globin genes.
Hum Biol 2001, 73: 661-674.
46. Talmaci R, Gavrila L: Detection of β-thalassemia alleles by the ARMS-PCR
method in Romania. Romanian Biotechnol Lett 2003, 8: 1241-1246.
47. Talmaci R, Traeger-Synodinos J, Kanavakis E, Coriu D, Colita D, Gavrila L:
Scanning of beta-globin gene for identification of beta-thalassemia mutation in
Romanian population. J Cell Mol Med 2004, 8: 232-240.
48. Thiebault K, Mazelin L, Pays L, Llambi F, Joly MO, Scoazec JY et al.:
The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death
commitment. Proc Natl Acad Sci U S A 2003, 100: 4173-4178.
49. Tsakris A, Hassapopoulou H, Skoura L, Pournaras S, Douboyas J: Leg ulcer
due to Pseudomanas luteola in a patient with sickle cell disease. Diagn
Microbiol Infect Dis 2002, 42: 141-143.
50. Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis
A et al.: Magnetic resonance imaging in the evaluation of iron overload in patients
with beta thalassaemia and sickle cell disease. Br J Haematol 2004,
126: 736-742.